Home » Posts tagged with » Ireland
CroíValve set to advance Tricuspid Coaptation Valve into clinical trial

CroíValve set to advance Tricuspid Coaptation Valve into clinical trial

CroíValve, an Irish medtech company spun out from Trinity College, has raised €4 million for developing a medical device called Tricuspid Coaptation Valve for the treatment of tricuspid regurgitation (TR), a severe heart condition. The financing secured by the Irish medtech firm includes €2.5 million from the European Union under its Horizon 2020 SME Instrument […]

Mallinckrodt to sell Canadian CDMO BioVectra to H.I.G. Capital for $250m

Mallinckrodt sale of BioVectra to H.I.G. Capital : Irish biopharma company Mallinckrodt has agreed to divest its wholly-owned subsidiary BioVectra, a Canadian CDMO (contract development and manufacturing organization) to an affiliate of H.I.G. Capital for nearly US$250 million, as per the latest pharma acquisition news. The transaction amount to be paid by H.I.G. Capital, which is […]

Continue reading …
Nabriva secures Xenleta FDA approval for community-acquired pneumonia

Xenleta FDA approval : Irish pharma company Nabriva Therapeutics has bagged approval from the US Food and Drug Administration for its semi-synthetic pleuromutilin antibiotic Xenleta (lefamulin) for the treatment of community-acquired bacterial pneumonia in adults. Community-acquired pneumonia is caused when someone develops pneumonia in the community, that is not in a hospital. Pneumonia is a […]

Continue reading …
Jazz Pharmaceuticals acquires Cavion, developer of essential tremor drugs

Jazz Pharmaceuticals acquisition of Cavion : Irish pharma company Jazz Pharmaceuticals has acquired US-based clinical-stage pharma company Cavion, a developer of essential tremor drugs, in a deal worth up to $312.5 million as per the latest pharma acquisition news. Based in Cambridge, Massachusetts, Cavion is engaged in developing therapies aimed at regulating the T-type calcium […]

Continue reading …
AbbVie to acquire Botox developer Allergan for $63bn

AbbVie acquisition of Allergan : US biopharma company AbbVie is all set to acquire Botox developer Allergan, an Irish pharma company, for $63 billion in a cash cum stock deal, as per pharma acquisition news. Headquartered in Chicago, AbbVie is engaged in developing drugs in areas such as immunology, oncology, neuroscience, and virology. On the […]

Continue reading …
Takeda acquisition of Shire : Japanese pharma company completes $62bn acquisition

Takeda acquisition of Shire : Japanese pharma company Takeda Pharmaceutical wrapped up its previously announced acquisition of Shire, an Irish biotech company with a focus on rare diseases, for $62 billion, as per the latest pharma acquisition news. Takeda acquisition of Shire It was in May 2018 when Takeda agreed to acquire the Irish rare […]

Continue reading …
Allergan acquisition of Bonti : Allergan to acquire US aesthetic company in $195m deal

Allergan acquisition of Bonti : Irish pharma company Allergan will acquire Bonti, a US aesthetic company, engaged in the development of fast-acting neurotoxin programs for aesthetic and therapeutic applications, in a deal worth over $195 million. Allergan Acquisition of Bonti | US Aesthetic Company in $195m Deal As per the terms of the Allergan acquisition […]

Continue reading …
Alkermes to evaluate ALKS 4230, pembrolizumab combo for solid tumors

Irish biopharma company Alkermes said that it has expanded an ongoing phase 1 trial for its immuno oncology drug ALKS 4230 to assess its safety and anti-tumor activity in combination with Merck’s PD-1 inhibitor KEYTRUDA (pembrolizumab) in advanced solid tumors. According to Alkermes, ALKS 4230 is an engineered fusion protein which selectively binds and signals […]

Continue reading …